Fund I (1996)
EndoMatrix
Endomatrix developed a novel approach for tissue bulking for treatment of such conditions as incontinence and gastroesophageal reflux.
Endomatrix was acquired in 1997 by CR Bard, Inc.
Endomatrix developed a novel approach for tissue bulking for treatment of such conditions as incontinence and gastroesophageal reflux.
Endomatrix was acquired in 1997 by CR Bard, Inc.
